Abstract:Infection of multidrug-resistant (MDR) bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Enterobacteriaceae (CRE), and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli, brings public health issues and causes economic burden. Pathogenic bacteria develop several methods to resist antibiotic killing or inhibition, such as mutation of antibiotic function sites, activation of drug efflux pumps, and enzyme-mediated drug degradation. Antibiotic resistance components can be transferred between bacteria by mobile genetic elements including plasmids, transposons, and integrons, as well as bacteriophages. The development of antibiotic resistance limits the treatment options for bacterial infection, especially for MDR bacteria. Therefore, novel or alternative antibacterial agents are urgently needed. Antimicrobial peptides (AMPs) display multiple killing mechanisms against bacterial infections, including directly bactericidal activity and immunomodulatory function, as potential alternatives to antibiotics. In this review, the development of antibiotic resistance, the killing mechanisms of AMPs, and especially, the design, optimization, and delivery of AMPs are reviewed. Strategies such as structural change, amino acid substitution, conjugation with cell-penetration peptide, terminal acetylation and amidation, and encapsulation with nanoparticles will improve the antimicrobial efficacy, reduce toxicity, and accomplish local delivery of AMPs. In addition, clinical trials in AMP studies or applications of AMPs within the last five years were summarized. Overall, AMPs display diverse mechanisms of action against infection of pathogenic bacteria, and future research studies and clinical investigations will accelerate AMP application.

Integrated computational approaches for advancing antimicrobial peptide development

Computational resources and tools for antimicrobial peptides

A foundation model approach to guide antimicrobial peptide design in the era of artificial intelligence driven scientific discovery

Computational Methods and Tools in Antimicrobial Peptide Research

Design methods for antimicrobial peptides with improved performance

Chemical modifications to increase the therapeutic potential of antimicrobial peptides

[Progress on the design and optimization of antimicrobial peptides]

Designing antimicrobial peptides using deep learning and molecular dynamic simulations

Advancements, challenges and future perspectives on peptide-based drugs: Focus on antimicrobial peptides

Using chemical synthesis to optimise antimicrobial peptides in the fight against antimicrobial resistance

Antimicrobial Peptides as Effective Agents Against Drug-Resistant Pathogens

Chemically modified and conjugated antimicrobial peptides against superbugs.

Antimicrobial Peptides: A Promising Solution to the Rising Threat of Antibiotic Resistance

From Membrane Composition to Antimicrobial Strategies: Experimental and Computational Approaches to AMP Design and Selectivity

A Foundation Model Identifies Broad-Spectrum Antimicrobial Peptides against Drug-Resistant Bacterial Infection

Antimicrobial Peptides: From Design to Clinical Application

From Membrane Composition to Antimicrobial Strategies: Experimental and Computational Approaches to AMP De- sign and Selectivity

Recent Progress in the Discovery and Design of Antimicrobial Peptides Using Traditional Machine Learning and Deep Learning

Synthetic molecular evolution of antimicrobial peptides

Antimicrobial peptides for combating drug-resistant bacterial infections

Advances in Antimicrobial Peptide Discovery via Machine Learning and Delivery via Nanotechnology